AHL Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$264K Sell
1,223
-6,468
-84% -$1.31M ﹤0.01% 1187
2017
Q3
$1.43M Buy
7,691
+726
+10% +$127K 0.03% 771
2017
Q2
$1.2M Sell
6,965
-10,824
-61% -$1.74M 0.03% 725
2017
Q1
$2.72M Buy
17,789
+12,018
+208% +$1.76M 0.06% 537
2016
Q4
$851K Sell
5,771
-12,253
-68% -$1.77M 0.03% 697
2016
Q3
$2.28M Sell
18,024
-4,017
-18% -$484K 0.08% 340
2016
Q2
$2.48M Buy
22,041
+19,274
+697% +$2M 0.13% 200
2016
Q1
$288K Sell
2,767
-1,633
-37% -$156K 0.02% 678
2015
Q4
$496K Sell
4,400
-2,053
-32% -$227K 0.04% 471
2015
Q3
$707K Sell
6,453
-13,964
-68% -$1.49M 0.11% 263
2015
Q2
$1.95M Buy
+20,417
New +$1.91M 0.08% 458

Other funds holding ICUI

AHL Partners's ICUI Position: Q4 2017 in Review

AHL Partners reduced its ICU Medical (ICUI) stake by 84% in Q4 2017, selling an estimated $1.31M and leaving 1,223 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

AHL Partners first reported a position in ICUI in Q2 2015 and has held it in 11 quarters since. The position peaked at $2.72M in Q1 2017. 259 funds tracked by Wall St. Rank hold ICUI as of Q4 2017.

  • AHL Partners held 1,223 shares of ICU Medical worth $264K as of Q4 2017.
  • AHL Partners sold 6,468 ICU Medical shares in Q4 2017, an estimated $1.31M.
  • ICU Medical made up ﹤0.01% of AHL Partners's portfolio in Q4 2017, its #1187 holding.
  • AHL Partners first reported a position in ICU Medical in Q2 2015 and has held it in 11 quarters since.
  • AHL Partners's ICU Medical position peaked at $2.72M in Q1 2017.
  • 259 funds tracked by Wall St. Rank held ICU Medical as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.